Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.
Saved in:
| Title: | Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results. |
|---|---|
| Authors: | Bachert C; Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Münster, Münster, Germany.; First Affiliated Hospital, Sun Yat-Sen University, International Airway Research Center, Guangzhou, China.; Upper Airways Research Laboratory, Faculty of Medicine, Ghent University, Ghent, Belgium., Laidlaw TM; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Cho SH; Division of Allergy-Immunology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA., Mullol J; Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain., Swanson BN; College of Life Sciences, Thomas Jefferson University, Philadelphia, PA, USA.; Research and Development, Sanofi, Bridgewater, NJ, USA., Naimi S; Molecular and Digital Histopathology, Sanofi, Vitry-sur-Seine, France., Classe M; Pathology Department, Institut Gustave Roussy, Villejuif, France.; Translational Sciences, Sanofi, Chilly-Mazarin, France., Harel S; Clinical Sciences Global Development, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Jagerschmidt A; Global Clinical Development, Sanofi, Chilly-Mazarin, France., Laws E; Immunology and Inflammation Global Development, Sanofi, Bridgewater, NJ, USA., Ruddy M; Clinical Sciences Global Development, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Praestgaard A; Department of Biostatistics, Sanofi, Cambridge, MA, USA., Amin N; Clinical Sciences Global Development, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Mannent LP; Global Clinical Development, Sanofi, Chilly-Mazarin, France. |
| Source: | The Annals of otology, rhinology, and laryngology [Ann Otol Rhinol Laryngol] 2023 Dec; Vol. 132 (12), pp. 1649-1661. Date of Electronic Publication: 2023 Jun 15. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Sage Country of Publication: United States NLM ID: 0407300 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-572X (Electronic) Linking ISSN: 00034894 NLM ISO Abbreviation: Ann Otol Rhinol Laryngol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37322842 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bachert+C%22">Bachert C</searchLink>; Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Münster, Münster, Germany.; First Affiliated Hospital, Sun Yat-Sen University, International Airway Research Center, Guangzhou, China.; Upper Airways Research Laboratory, Faculty of Medicine, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Laidlaw+TM%22">Laidlaw TM</searchLink>; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cho+SH%22">Cho SH</searchLink>; Division of Allergy-Immunology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Mullol+J%22">Mullol J</searchLink>; Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Swanson+BN%22">Swanson BN</searchLink>; College of Life Sciences, Thomas Jefferson University, Philadelphia, PA, USA.; Research and Development, Sanofi, Bridgewater, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Naimi+S%22">Naimi S</searchLink>; Molecular and Digital Histopathology, Sanofi, Vitry-sur-Seine, France.<br /><searchLink fieldCode="AU" term="%22Classe+M%22">Classe M</searchLink>; Pathology Department, Institut Gustave Roussy, Villejuif, France.; Translational Sciences, Sanofi, Chilly-Mazarin, France.<br /><searchLink fieldCode="AU" term="%22Harel+S%22">Harel S</searchLink>; Clinical Sciences Global Development, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Jagerschmidt+A%22">Jagerschmidt A</searchLink>; Global Clinical Development, Sanofi, Chilly-Mazarin, France.<br /><searchLink fieldCode="AU" term="%22Laws+E%22">Laws E</searchLink>; Immunology and Inflammation Global Development, Sanofi, Bridgewater, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Ruddy+M%22">Ruddy M</searchLink>; Clinical Sciences Global Development, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Praestgaard+A%22">Praestgaard A</searchLink>; Department of Biostatistics, Sanofi, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Amin+N%22">Amin N</searchLink>; Clinical Sciences Global Development, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Mannent+LP%22">Mannent LP</searchLink>; Global Clinical Development, Sanofi, Chilly-Mazarin, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220407300%22">The Annals of otology, rhinology, and laryngology</searchLink> [Ann Otol Rhinol Laryngol] 2023 Dec; Vol. 132 (12), pp. 1649-1661. <i>Date of Electronic Publication: </i>2023 Jun 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0407300 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1943-572X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200034894%22">00034894 </searchLink><i>NLM ISO Abbreviation: </i>Ann Otol Rhinol Laryngol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37322842 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/00034894231176334 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1649 Titles: – TitleFull: Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bachert C – PersonEntity: Name: NameFull: Laidlaw TM – PersonEntity: Name: NameFull: Cho SH – PersonEntity: Name: NameFull: Mullol J – PersonEntity: Name: NameFull: Swanson BN – PersonEntity: Name: NameFull: Naimi S – PersonEntity: Name: NameFull: Classe M – PersonEntity: Name: NameFull: Harel S – PersonEntity: Name: NameFull: Jagerschmidt A – PersonEntity: Name: NameFull: Laws E – PersonEntity: Name: NameFull: Ruddy M – PersonEntity: Name: NameFull: Praestgaard A – PersonEntity: Name: NameFull: Amin N – PersonEntity: Name: NameFull: Mannent LP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2023 Dec Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1943-572X Numbering: – Type: volume Value: 132 – Type: issue Value: 12 Titles: – TitleFull: The Annals of otology, rhinology, and laryngology Type: main |
| ResultId | 1 |